- 全部删除
 
您的购物车当前为空
Ki16198 是一种可口服的 LPA 受体拮抗剂,是 Ki16425 的甲酯衍生物。它抑制 LPA1 和 LPA3 诱导的肌醇磷酸的Ki值分别为 0.34 和 0.93 μM,可用于胰腺癌发生和转移的研究。


为众多的药物研发团队赋能,
让新药发现更简单!
Ki16198 是一种可口服的 LPA 受体拮抗剂,是 Ki16425 的甲酯衍生物。它抑制 LPA1 和 LPA3 诱导的肌醇磷酸的Ki值分别为 0.34 和 0.93 μM,可用于胰腺癌发生和转移的研究。
| 规格 | 价格 | 库存 | 数量 | 
|---|---|---|---|
| 1 mg | ¥ 118  | In stock | |
| 5 mg | ¥ 296  | In stock | |
| 10 mg | ¥ 500  | In stock | |
| 25 mg | ¥ 1,030  | In stock | |
| 50 mg | ¥ 1,570  | In stock | |
| 100 mg | ¥ 2,230  | In stock | |
| 200 mg | ¥ 2,970  | In stock | |
| 1 mL x 10 mM (in DMSO) | ¥ 328  | In stock | 
Ki16198 相关产品
| 产品描述 | Ki16198 is an orally available LPA receptor antagonist and is a methyl ester derivative of Ki16425. It inhibits LPA1- and LPA3-induced inositol phosphates with Ki values of 0.34 and 0.93 μM, respectively, and can be used in studies of pancreatic carcinogenesis and metastasis.  | 
| 靶点活性 |  LPA1:0.34 μM(Ki), LPA3:0.93 μM(Ki)  | 
| 分子量 | 488.98 | 
| 分子式 | C24H25ClN2O5S | 
| CAS No. | 355025-13-7 | 
| Smiles | COC(=O)CCSCc1ccc(cc1)-c1onc(C)c1NC(=O)OC(C)c1ccccc1Cl | 
| 密度 | no data available | 
| 存储 | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice/Shipping at ambient temperature. | ||||||||||||||||||||||||||||||||||||||||
| 溶解度信息 | DMSO: 50 mg/mL (102.25 mM), Sonication is recommended.  Ethanol: 33 mg/mL (67.49 mM), Sonication is recommended.  H2O: < 1 mg/mL (insoluble or slightly soluble)   | ||||||||||||||||||||||||||||||||||||||||
溶液配制表  | |||||||||||||||||||||||||||||||||||||||||
Ethanol/DMSO 
 DMSO 
  | |||||||||||||||||||||||||||||||||||||||||
评论内容